Louise Bennet

Senior consultant, Clinical Trial Unit SUS Lund, MD PhD Associate Professor Family Medicine, PI, Adjunct lecturer, Affiliated with the university

Personal profile


My research focuses on type 2 diabetes, metabolism and complications in vulnerable populations. I am PI for the MEDIM study consisting of a cohort of 2200 participants, a culturally adapted randomized controlled lifestyle intervention study and an experimental metabolic study. The MEDIM has contributed to three thesis at Lund University. See a more detailed description of MEDIM's output under Projects and Dissertations. 

I am regional PI for the nationwide multicenter clinical trial SMARTEST, sponsored by Uppsala University. The study seeks to answer the question of whether SGLT2 inhibitors to a greater extent than metformin protect against the onset of diabetic complications, in people who have recently developed type 2 diabetes.

Further I am PI for a project within COVERS at Lund University, studying attitudes towards participating in a vaccination program as part of an international collaboration with Paris Saclay University in Paris within EUGLOH (The European Universities Alliance for Global Health).


Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 4 - Quality Education

UKÄ subject classification

  • Endocrinology and Diabetes
  • Public Health, Global Health, Social Medicine and Epidemiology


Dive into the research topics where Louise Bennet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or